These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 3025881)

  • 1. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.
    Henle W; Henle G; Andersson J; Ernberg I; Klein G; Horwitz CA; Marklund G; Rymo L; Wellinder C; Straus SE
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):570-4. PubMed ID: 3025881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
    Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
    Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Huang J; Tengvall K; Lima IB; Hedström AK; Butt J; Brenner N; Gyllenberg A; Stridh P; Khademi M; Ernberg I; Al Nimer F; Manouchehrinia A; Hillert J; Alfredsson L; Andersen O; Sundström P; Waterboer T; Olsson T; Kockum I
    Brain; 2024 Oct; 147(10):3573-3582. PubMed ID: 38630618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigens.
    Dillner J; Kallin B; Ehlin-Henriksson B; Rymo L; Henle W; Henle G; Klein G
    Int J Cancer; 1986 Feb; 37(2):195-200. PubMed ID: 2417963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
    Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
    Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
    Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
    J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virus.
    Pedneault L; Lapointe N; Alfieri C; Ghadirian P; Carpentier L; Samson J; Joncas J
    Clin Infect Dis; 1996 Oct; 23(4):806-8. PubMed ID: 8909848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6.
    Lennette ET; Rymo L; Yadav M; Masucci G; Merk K; Timar L; Klein G
    Eur J Cancer; 1993; 29A(11):1584-9. PubMed ID: 8217366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer.
    Miller G; Grogan E; Fischer DK; Niederman JC; Schooley RT; Henle W; Lenoir G; Liu CR
    N Engl J Med; 1985 Mar; 312(12):750-5. PubMed ID: 2983211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
    Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals.
    Seigneurin JM; Lavoue MF; Genoulaz O; Bornkamm GW; Lenoir GM
    Int J Cancer; 1987 Sep; 40(3):349-53. PubMed ID: 3040599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.
    Bertrand KA; Birmann BM; Chang ET; Spiegelman D; Aster JC; Zhang SM; Laden F
    Blood; 2010 Nov; 116(18):3547-53. PubMed ID: 20647565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection.
    Miller G; Grogan E; Rowe D; Rooney C; Heston L; Eastman R; Andiman W; Niederman J; Lenoir G; Henle W
    J Infect Dis; 1987 Jul; 156(1):26-35. PubMed ID: 3036961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
    Incaprera M; Rindi L; Bazzichi A; Garzelli C
    Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.